US Stock MarketDetailed Quotes

SCLX Scilex Holding

Watchlist
  • 4.820
  • -0.370-7.13%
Close Jun 13 16:00 ET
  • 4.820
  • 0.0000.00%
Post 16:04 ET
33.51MMarket Cap-0.32P/E (TTM)
Post-Market
  • 5D
  • Daily
  • Weekly
  • Monthly
  • 1Q
  • 1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

Comments

    $Scilex Holding (SCLX.US)$ Scilex Holding Announces Publication On GLOPERBA Dosing Adjustments In Peer-Review Journal
    Benzinga
    5 mins ago
    Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company"))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced a publication on GLOPERBA dosing adjustments in peer-...
    $Scilex Holding (SCLX.US)$ Scilex Holding Presents Post-Hoc Analysis of C.L.E.A.R. Trial On Clinical Meaningfulness Of Safety And Efficacy Of SP-102 For Treatment of Lumbosacral Radicular Pain at ASIPP 2025
    Benzinga· 3 mins ago
    Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company"))), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and card...
    2
    $Scilex Holding (SCLX.US)$
    Scilex Holding Company Regains Compliance with NASDAQ Minimum Bid Price Rule
    Wednesday, 30th April at 1:46 pm
    PALO ALTO, Calif., April 30, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ: SCLX, "Scilex" or "Company")), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and neurodegenerative and cardiometabolic disease, today announced th...
    $Scilex Holding (SCLX.US)$
    Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex's Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from April 11, 2025 to May 2, 2025
    Tuesday, 22nd April at 9:00 am
    PALO ALTO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ: SCLX, "Scilex" or "Company")), an innovative revenue-generating company focused on acqu...
    $Scilex Holding (SCLX.US)$  Did DECA listing on OTC market causes sclx to drop 21% ? @Trytosaveabit
    2
Read more

Market Insights

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.

Discussing

FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma Show More